Statement of Cash Flows	7 Months Ended
	Dec. 31, 2019 USD ($)
Cash Flows from Operating Activities:
Net income	$ 655,679
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(1,197,637)
Unrealized gain on marketable securities held in Trust Account	(17,194)
Deferred tax provision	3,611
Changes in operating assets and liabilities:
Prepaid expenses	(131,226)
Accounts payable and accrued expenses	240,138
Income tax payable	25,684
Net cash used in operating activities	(420,945)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	225,400,000
Proceeds from sale of Private Placement Warrants	6,100,000
Advances from Sponsor	600,000
Payment of advances from Sponsor	(600,000)
Proceeds from promissory note - related party	155,093
Repayment of promissory note - related party	(155,093)
Payment of offering costs	(585,927)
Net cash provided by financing activities	230,914,073
Net Change in Cash	493,128
Cash - Beginning of period
Cash - End of period	493,128
Non-Cash investing and financing activities:
Initial classification of common stock subject to redemption	217,862,910
Change in value of common stock subject to redemption	656,838
Deferred offering costs paid directly by Sponsor from proceeds from issuance of common stock	25,000
Deferred offering fee payable	$ 8,050,000